Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,945 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How can gastroenterology training thrive in a post-COVID world?
FitzPatrick M, Clough J, Harvey P, Ratcliffe E. FitzPatrick M, et al. Among authors: harvey p. Frontline Gastroenterol. 2020 Aug 21;12(4):338-341. doi: 10.1136/flgastro-2020-101601. eCollection 2021. Frontline Gastroenterol. 2020. PMID: 34249320 Free PMC article. No abstract available.
Women in gastroenterology: the UK trainee experience.
Sethi S, Kumar A, Clough J, Ravindran S, Harris R, Harvey P, Raju S, Brookes MJ, Rutter CS, Steed H. Sethi S, et al. Among authors: harvey p. Frontline Gastroenterol. 2022 Mar 1;13(6):484-489. doi: 10.1136/flgastro-2022-102101. eCollection 2022. Frontline Gastroenterol. 2022. PMID: 36250176 Free PMC article.
Managing a patient with globus pharyngeus.
Harvey PR, Theron BT, Trudgill NJ. Harvey PR, et al. Frontline Gastroenterol. 2018 Jul;9(3):208-212. doi: 10.1136/flgastro-2017-100844. Epub 2017 Aug 5. Frontline Gastroenterol. 2018. PMID: 30046425 Free PMC article.
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J, Cooney R, Croft NM, Hart AL, Irving PM, Kok KB, Lamb CA, Limdi JK, Macdonald J, McGovern DP, Mehta SJ, Murray CD, Patel KV, Pollok RC, Raine T, Russell RK, Selinger CP, Smith PJ, Bowden J, McDonald TJ, Lees CW, Sebastian S, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Gut. 2021 May;70(5):865-875. doi: 10.1136/gutjnl-2021-324388. Epub 2021 Mar 22. Gut. 2021. PMID: 33753421
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Lin S, Kennedy NA, Saifuddin A, Sandoval DM, Reynolds CJ, Seoane RC, Kottoor SH, Pieper FP, Lin KM, Butler DK, Chanchlani N, Nice R, Chee D, Bewshea C, Janjua M, McDonald TJ, Sebastian S, Alexander JL, Constable L, Lee JC, Murray CD, Hart AL, Irving PM, Jones GR, Kok KB, Lamb CA, Lees CW, Altmann DM, Boyton RJ, Goodhand JR, Powell N, Ahmad T; CLARITY IBD study. Lin S, et al. Nat Commun. 2022 Mar 16;13(1):1379. doi: 10.1038/s41467-022-28517-z. Nat Commun. 2022. PMID: 35296643 Free PMC article.
1,945 results